MedTrace Logo

The Incidence of Venous Thromboembolism in Atopic Dermatitis

NCT04969653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 754745

Last updated 2024-12-09

Study results available
· View outcomes & findings →

Summary

This study aims to investigate the incidence of venous thromboembolism in people who are diagnosed with atopic dermatitis.

Conditions

Interventions

OTHER

Exposure of venous thromboembolism

Composite of pulmonary embolism and deep vein thrombosis

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Momentum Data

    lead INDUSTRY

Principal Investigators

  • Andrew McGovern, MD · Momentum Data Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2023-03-31
Completion
2023-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969653 on ClinicalTrials.gov